(CD5E) Amundi Index Solutions - Ratings and Ratios

Exchange: SW • Country: Switzerland • Currency: EUR • Type: Etf • ISIN: LU1681047319

European Stocks, Index Funds, Large Cap Stocks

Description: CD5E Amundi Index Solutions

The Amundi EURO STOXX50 UCITS ETF-D EUR is an exchange-traded fund (ETF) designed to replicate the performance of the EURO STOXX50 Index, a benchmark comprising the 50 largest and most liquid stocks in the Eurozone. The funds primary objective is to minimize the tracking error between its net asset value and the indexs performance.

With Assets Under Management (AUM) of approximately 793.83 million EUR, this ETF is a sizable player in the Eurozone Large-Cap Equity category. Its liquidity and trading volume can be inferred from its listing on the Swiss market, with a ticker symbol of CD5E.

From a performance perspective, the ETF has demonstrated a strong upward trend, with its current price of 85.82 EUR being close to its 52-week high of 88.00 EUR. The funds short-term moving averages (SMA20 and SMA50) are in close proximity, indicating a stable short-term outlook. The longer-term SMA200 is significantly lower, suggesting a strong uptrend over the past year. The Average True Range (ATR) of 0.53 EUR, or 0.62%, indicates relatively moderate volatility.

Key Performance Indicators (KPIs) for this ETF include its tracking error, which is crucial in evaluating its ability to replicate the EURO STOXX50 Index. Other relevant KPIs include its expense ratio, trading volume, and bid-ask spread, which can impact its overall cost and liquidity. As a Trading Analyst, it is essential to monitor these KPIs to ensure that the ETF remains an optimal investment choice.

To further evaluate this ETF, one could analyze its sector and stock holdings to understand its underlying composition and potential risks. Additionally, comparing its performance and KPIs to those of similar ETFs in the Eurozone Large-Cap Equity category can provide valuable insights into its relative strengths and weaknesses.

Additional Sources for CD5E ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CD5E ETF Overview

Market Cap in USD 927m
Category Eurozone Large-Cap Equity
TER 0.09%
IPO / Inception 2018-02-14

CD5E ETF Ratings

Growth Rating 48.8
Fundamental -
Dividend Rating 52.8
Rel. Strength -0.81
Analysts -
Fair Price Momentum 86.57 EUR
Fair Price DCF -

CD5E Dividends

Dividend Yield 12m 2.69%
Yield on Cost 5y 4.34%
Annual Growth 5y 4.40%
Payout Consistency 100.0%
Payout Ratio %

CD5E Growth Ratios

Growth Correlation 3m 51.1%
Growth Correlation 12m 91%
Growth Correlation 5y 91%
CAGR 5y 74.08%
CAGR/Max DD 5y 3.31
Sharpe Ratio 12m 0.86
Alpha 64.72
Beta 0.558
Volatility 15.83%
Current Volume 7.1k
Average Volume 20d 0.9k
Stop Loss 84.7 (-3.5%)
What is the price of CD5E shares?
As of July 15, 2025, the stock is trading at EUR 87.80 with a total of 7,111 shares traded.
Over the past week, the price has changed by +1.94%, over one month by +2.91%, over three months by +13.28% and over the past year by +13.99%.
Is Amundi Index Solutions a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, Amundi Index Solutions (SW:CD5E) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 48.81 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CD5E is around 86.57 EUR . This means that CD5E is currently overvalued and has a potential downside of -1.4%.
Is CD5E a buy, sell or hold?
Amundi Index Solutions has no consensus analysts rating.
What are the forecasts for CD5E share price target?
According to our own proprietary Forecast Model, CD5E Amundi Index Solutions will be worth about 97.8 in July 2026. The stock is currently trading at 87.80. This means that the stock has a potential upside of +11.33%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 97.8 11.3%